Table 2.
Percent Change* | 95% Confidence Interval | |
---|---|---|
Age (per year change) | −0.30 | −0.74 to 0.15 |
Female sex | 1.46 | −2.86 to 5.77 |
Diagnosis group | ||
Group A, COPD | Reference | Reference |
Group B, pulmonary hypertension | 18.64 | 2.00–35.29 |
Group C, cystic fibrosis | –26.52 | –8.00 to –45.04 |
Group D, pulmonary fibrosis | 5.31 | −3.11 to 13.73 |
Single transplant procedure | –26.23 | –18.66 to –33.80 |
Pretransplant life support | 40.02 | 24.37–55.67 |
Lung allocation score | ||
<35 | Reference | Reference |
35–40 | 10.21 | 0.5–19.92 |
40–50 | 14.93 | 3.86–26.01 |
>50 | 25.04 | 11.27–38.81 |
Center volume | ||
Low | 11.66 | 0.5–22.79 |
Intermediate | 11.67 | −1.74 to 25.07 |
High | Reference | Reference |
Definition of abbreviation: COPD = chronic obstructive pulmonary disease.
Significant associations are presented in boldface.
Reflects percent change from the reference model cost of $144,770.